Organon OGN
NYSE OGN
$13.75 +0.01 (+0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Organon (OGN) Goodwill & Intangibles (2020 - 2026)

Organon (OGN) posted quarterly Goodwill & Intangibles of $5.3 billion for Q2 2026, down 12.86% year-over-year from $6.0 billion in Q2 2025, and little changed on a QoQ basis from $5.3 billion in Q1 2026.

Organon (OGN) Goodwill & Intangibles (2020 - 2026) Analysis & Trends

Organon has reported Goodwill & Intangibles for 7 years, with the latest figure at $5.3 billion in Q2 2026.

  • Goodwill & Intangibles for Q2 2026 came in at $5.3 billion, down 12.86% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.3 billion (down 12.86% YoY), and the FY2025 annual result was $5.3 billion, down 13.31% from the prior year.
  • Goodwill & Intangibles steadied at $5.3 billion in Q2 2026, from $5.3 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $29.1 billion in Q4 2023 and troughed at $4.7 billion in Q3 2025.
  • A 5-year average of $6.6 billion and a median of $5.3 billion in 2022 frame the typical range for Goodwill & Intangibles.
  • The widest annual swing landed in 2023, when Goodwill & Intangibles soared 454.53%; it then tumbled 79.08% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $5.3 billion in 2022, then soared by 454.53% to $29.1 billion in 2023, then tumbled by 79.08% to $6.1 billion in 2024, then dropped by 13.31% to $5.3 billion in 2025, then dropped by 0.34% to $5.3 billion in 2026.
  • Per Business Quant data, the three most recent Goodwill & Intangibles figures were $5.3 billion in Q2 2026, $5.3 billion in Q1 2026, and $5.3 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Organon 3.61 Bn 2.48 Bn 847.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.27 Bn
Mar 31, 2026 5.25 Bn
Dec 31, 2025 5.28 Bn
Sep 30, 2025 4.71 Bn
Jun 30, 2025 6.04 Bn
Mar 31, 2025 4.73 Bn
Dec 31, 2024 6.09 Bn
Sep 30, 2024 4.72 Bn
Jun 30, 2024 5.29 Bn
Mar 31, 2024 4.82 Bn
Dec 31, 2023 5.14 Bn
Sep 30, 2023 5.16 Bn
Jun 30, 2023 5.20 Bn
Mar 31, 2023 5.22 Bn
Dec 31, 2022 5.25 Bn
Sep 30, 2022 5.27 Bn
Jun 30, 2022 5.24 Bn
Mar 31, 2022 5.27 Bn
Dec 31, 2021 5.25 Bn
Sep 30, 2021 5.29 Bn